Trigeminal neuralgia is a chronic pain condition that causes sudden, intense jolts of facial pain, often described as feeling like an electric shock. It affects one of the largest nerves in your head, the trigeminal nerve, which carries sensation from your face to your brain. The condition strikes about 25 per 100,000 people each year, with women affected nearly twice as often as men.
What the Pain Feels Like
The hallmark of trigeminal neuralgia is a burst of severe, stabbing or shooting pain on one side of the face. Each episode typically lasts from a fraction of a second to about two minutes, but the intensity is extreme. People commonly describe it as one of the worst pains they’ve ever experienced. The pain hits suddenly, often without warning, and can come in rapid-fire clusters throughout the day before disappearing for weeks or months at a time.
What makes this condition especially disruptive is that ordinary, harmless activities can set off an attack. Common triggers include brushing your teeth, chewing, drinking, shaving, touching your face, talking, smiling, washing your face, putting on makeup, or even a light breeze against your skin. Over time, many people start avoiding these triggers, which can interfere with eating, personal hygiene, and social interaction.
The pain almost always affects just one side of the face. Bilateral pain (both sides) is rare and, when it does occur, is most often linked to multiple sclerosis.
Why It Happens
In most cases, trigeminal neuralgia develops because a blood vessel presses against the trigeminal nerve near the point where it enters the brainstem. This spot, called the root entry zone, is particularly vulnerable. The sustained pressure from the vessel gradually damages the nerve’s protective insulating layer, a process called demyelination. Once that insulation breaks down, the nerve begins to fire on its own, sending pain signals to the brain in response to stimuli that shouldn’t hurt at all.
The condition falls into three categories. Classical trigeminal neuralgia is diagnosed when imaging confirms that a blood vessel is compressing and physically distorting the nerve. Secondary trigeminal neuralgia results from another neurological disease. The most common culprits are multiple sclerosis and tumors near the base of the brain. About 2% to 5% of people with MS develop trigeminal neuralgia. In MS, patches of nerve damage in the brainstem or increased vulnerability of the trigeminal nerve root can trigger the pain. In roughly 11% of cases, no clear cause is found even after thorough testing, and the condition is classified as idiopathic.
How It’s Diagnosed
There’s no single blood test or scan that confirms trigeminal neuralgia on its own. Diagnosis starts with your description of the pain. Doctors look for a specific pattern: recurring episodes of one-sided facial pain that is severe, electric shock-like or stabbing, lasts seconds to two minutes, and is triggered by everyday touch or movement within the area the trigeminal nerve serves.
An MRI is the key imaging tool. High-resolution scans can reveal whether a blood vessel is pressing against and reshaping the trigeminal nerve, which points to classical trigeminal neuralgia. Specialized MRI sequences provide extremely detailed views of the nerve and surrounding blood vessels, making it possible to distinguish between a vessel simply touching the nerve (which is common and usually harmless) and one that’s actually compressing it enough to cause damage. If no vascular compression is visible, the same MRI can detect other potential causes like MS plaques or tumors, helping rule in or rule out secondary trigeminal neuralgia.
First-Line Treatment: Medication
Most people with trigeminal neuralgia respond well to medication, at least initially. Two anti-seizure drugs are the standard first-line options. Both work by calming overactive nerve signaling, reducing the frequency and intensity of pain attacks.
The more established option has been used for decades and is effective for the majority of patients. It’s typically started at a low dose taken twice daily and gradually increased until the pain is controlled. Side effects can include drowsiness, dizziness, nausea, double vision, and memory difficulties. More serious reactions are uncommon but possible, so regular blood monitoring is usually recommended.
The newer alternative works through a similar mechanism but is processed differently by the body, which generally means fewer side effects and fewer interactions with other medications. It’s often tried when the first option causes intolerable side effects, though about 25% of people who react poorly to one will also react to the other.
For many people, medication works well for years. But the condition can worsen over time, and some patients find that their medication becomes less effective or that side effects become harder to tolerate. When that happens, surgical options come into consideration.
Surgical Options When Medication Fails
The most definitive surgical treatment is microvascular decompression, an open procedure in which a surgeon physically moves the offending blood vessel away from the trigeminal nerve and places a small cushion between them. This addresses the root cause rather than just dampening symptoms. The long-term success rate is approximately 80%, making it the most durable option available. It does require general anesthesia and a small opening in the skull, so it carries the typical risks of neurosurgery: infection, bleeding, spinal fluid leakage, and rare but serious complications like hearing loss or stroke.
For people who aren’t good candidates for open surgery, whether due to age, other health conditions, or personal preference, less invasive alternatives exist. Percutaneous procedures involve inserting a needle through the cheek to reach the nerve cluster near the base of the skull. One approach uses a chemical injection to damage the nerve fibers selectively. Pain relief from this method is typically immediate, though the trade-off is that some degree of facial numbness often results, and pain recurrence rates are higher than with microvascular decompression.
Stereotactic radiosurgery takes a different approach entirely. It uses focused radiation beams to target the trigeminal nerve without any incision. The procedure itself is painless and doesn’t require general anesthesia, but the relief is not instant. The median time to noticeable pain improvement is around six months. This makes it a reasonable choice for patients who can manage their pain with medication in the interim and want to avoid more invasive procedures.
Living With Trigeminal Neuralgia
The unpredictable nature of this condition is often as challenging as the pain itself. Many people experience periods of remission lasting weeks to months, followed by flare-ups that can be devastating. During active periods, even routine tasks like eating or speaking can trigger attacks, which takes a real toll on quality of life, mood, and social connection.
If you’re dealing with facial pain that fits this pattern, the most useful first step is getting a proper diagnosis with high-resolution MRI. Knowing whether the cause is vascular compression, an underlying disease like MS, or something else entirely shapes every treatment decision that follows. The majority of people find meaningful relief through medication, surgery, or a combination of both, but the path to the right treatment is often a process of trial and adjustment over time.